BCL2L2 is an anti-apoptotic protein that has an oncogenic role in many solid tumor types, and it has been found to contribute to breast cancer progression through its upregulation via hypermethylation of the negative-regulatory miR-129-2 (81). Here, BCL2L2 is linked to breast cancer.